LeadIQ logo
Learn more at LeadIQ.com

Insights

Innovative Drug Technology Osmotica's expertise in osmotic drug delivery positions it as a leader in advanced pharmaceutical formulations, offering potential sales opportunities for partners specializing in drug delivery systems and proprietary manufacturing technologies.

Global Market Expansion With a strategic focus on addressing the growing global patient needs, Osmotica's ongoing development and commercialization efforts indicate opportunities to collaborate on new therapeutic products and expand into emerging markets.

Recent Brand Development The company's recent partnership with Brand Institute to develop the RELEXXII® brand demonstrates an active effort to enhance product recognition, opening avenues for marketing and branding specialists to support product launches and market penetration.

Financial Growth Potential Osmotica's revenue in the range of $50 million to $100 million, along with recent funding, suggests scope for scaling operations and increasing sales pipelines through targeted outreach to healthcare providers and distribution channels.

Strategic Market Position As a smaller but innovative pharmaceutical player with strategic subsidiaries like Vertical Pharmaceuticals and Trigen Laboratories, Osmotica presents opportunities for sales partnerships with distributors and contract manufacturing organizations aiming to serve niche or specialty markets.

Osmotica Pharmaceutical Corp. Tech Stack

Osmotica Pharmaceutical Corp. uses 8 technology products and services including Cloudflare CDN, Cloudflare, Microsoft Dynamics AX, and more. Explore Osmotica Pharmaceutical Corp.'s tech stack below.

  • Cloudflare CDN
    Content Delivery Network
  • Cloudflare
    Content Management System
  • Microsoft Dynamics AX
    Enterprise Resource Planning
  • ADP
    Human Resource Management System
  • yepnope.js
    Javascript Frameworks
  • jQuery
    Javascript Libraries
  • New Relic
    Real User Monitoring
  • Apache
    Web Servers

Osmotica Pharmaceutical Corp.'s Email Address Formats

Osmotica Pharmaceutical Corp. uses at least 1 format(s):
Osmotica Pharmaceutical Corp. Email FormatsExamplePercentage
FLast@osmotica.comJDoe@osmotica.com
83%
Last@osmotica.comDoe@osmotica.com
12%
First.Last@osmotica.comJohn.Doe@osmotica.com
4%
First@osmotica.comJohn@osmotica.com
1%

Frequently Asked Questions

Where is Osmotica Pharmaceutical Corp.'s headquarters located?

Minus sign iconPlus sign iconOsmotica Pharmaceutical Corp.'s main headquarters is located at 400 Crossing Boulevard Bridgewater, New Jersey 08807 United States. The company has employees across 4 continents, including North AmericaSouth AmericaEurope.

What is Osmotica Pharmaceutical Corp.'s phone number?

Minus sign iconPlus sign icon You can contact Osmotica Pharmaceutical Corp.'s main corporate office by phone at
+1-770-509-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Osmotica Pharmaceutical Corp.'s official website and social media links?

Minus sign iconPlus sign iconOsmotica Pharmaceutical Corp.'s official website is osmotica.com and has social profiles on LinkedInCrunchbase.

How much revenue does Osmotica Pharmaceutical Corp. generate?

Minus sign iconPlus sign icon As of March 2026, Osmotica Pharmaceutical Corp.'s annual revenue is estimated to be $7M.

What is Osmotica Pharmaceutical Corp.'s SIC code NAICS code?

Minus sign iconPlus sign iconOsmotica Pharmaceutical Corp.'s SIC code is 5122 - Drugs, Drug Proprietaries, and Druggists' Sundries NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Osmotica Pharmaceutical Corp. have currently?

Minus sign iconPlus sign iconAs of March 2026, Osmotica Pharmaceutical Corp. has approximately 130 employees across 4 continents, including North AmericaSouth AmericaEurope. Key team members include Vice President Supply Chain & Procurement: J. R.Vice President Supply Chain: B. M.Vice President Of Marketing: G. C.. Explore Osmotica Pharmaceutical Corp.'s employee directory with LeadIQ.

What industry does Osmotica Pharmaceutical Corp. belong to?

Minus sign iconPlus sign iconOsmotica Pharmaceutical Corp. operates in the Pharmaceutical Manufacturing industry.

What technology does Osmotica Pharmaceutical Corp. use?

Minus sign iconPlus sign iconOsmotica Pharmaceutical Corp.'s tech stack includes Cloudflare CDNCloudflareMicrosoft Dynamics AXADPyepnope.jsjQueryNew RelicApache.

What is Osmotica Pharmaceutical Corp.'s email format?

Minus sign iconPlus sign iconOsmotica Pharmaceutical Corp.'s email format typically follows the pattern of FLast@osmotica.com. Find more Osmotica Pharmaceutical Corp. email formats with LeadIQ.

How much funding has Osmotica Pharmaceutical Corp. raised to date?

Minus sign iconPlus sign icon As of March 2026, Osmotica Pharmaceutical Corp. has raised $35M in funding. The last funding round occurred on Oct 07, 2021 for $35M.

Osmotica Pharmaceutical Corp.

Pharmaceutical ManufacturingNew Jersey, United States51-200 Employees

Osmotica Pharmaceutical is a fully-integrated pharmaceutical company with demonstrated expertise in developing commercially successful products. As one of the world's leading osmotic drug delivery companies, we leverage our significant resources in R&D and proprietary drug delivery technology to address the growing need of the global patient population. 

We have the resources and experience to successfully commercialize our products through our subsidiaries, Vertical Pharmaceuticals, LLC and Trigen Laboratories, LLC.

For more company information, please visit our websites:
www.Osmotica.com
www.VerticalPharma.com
www.TrigenLab.com

Section iconCompany Overview

Headquarters
400 Crossing Boulevard Bridgewater, New Jersey 08807 United States
Phone number
+1-770-509-****
Website
osmotica.com
SIC Code
5122 - Drugs, Drug Proprietaries, and Druggists' Sundries
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $35M

    Osmotica Pharmaceutical Corp. has raised a total of $35M of funding over 3 rounds. Their latest funding round was raised on Oct 07, 2021 in the amount of $35M.

  • $50M$100M

    Osmotica Pharmaceutical Corp.'s revenue is estimated to be in the range of $50M$100M

Section iconFunding & Financials

  • $35M

    Osmotica Pharmaceutical Corp. has raised a total of $35M of funding over 3 rounds. Their latest funding round was raised on Oct 07, 2021 in the amount of $35M.

  • $50M$100M

    Osmotica Pharmaceutical Corp.'s revenue is estimated to be in the range of $50M$100M

Company Leadership

  • Stylized image of a person
    J. R.
    Vice President Supply Chain & Procurement
    Phone icon
    Mobile Phone
  • Stylized image of a person
    B. M.
    Vice President Supply Chain
    Phone icon
    Mobile Phone
  • Stylized image of a person
    G. C.
    Vice President Of Marketing
    Phone icon
    Mobile Phone
  • Stylized image of a person
    D. M.
    President / Ceo
    Phone icon
    Mobile Phone
  • Stylized image of a person
    B. M.
    Chairman And Chief Executive Officer
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    G. S.
    Global Head Of Analytical Sciences
    Phone icon
    Mobile Phone
  • Stylized image of a person
    A. C.
    Vice President
    Phone icon
    Mobile Phone
  • Stylized image of a person
    B. M.
    Vice President Supply Chain
    Phone icon
    Mobile Phone
  • Stylized image of a person
    G. C.
    Vice President Of Marketing
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. M.
    Evp, Human Resources
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.